Full recovery of a patient with COVID-19-induced acute kidney injury

Abdelaziz, Neama; Ghozy, Sherief; Abbas, Alzhraa Salah; Reda, Abdullah; El‐Qushayri, Amr Ehab; Islam, Sheikh Mohammed Shariful

doi:10.24911/ejmcr/173-1605961968

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Colestyramine, activated charcoal, and colestipol have been validated as efficacious management modalities in such situations, which have been proven to be acting by binding to digoxin within the gastrointestinal tract and reducing its absorption. [13][14][15][16] This has significantly lead to an increase in the systematic clearance of the compound. In addition, it enhanced excretion within the stool.…”

Section: Management Of Digitalis Toxicitymentioning

confidence: 99%

Systematic treatment and prevention of cardiac digoxin toxicity

Alshaer

Binobaid

Mofti

et al. 2021

Int J Community Med Public Health

View full text Add to dashboard Cite

Digoxin has a narrow therapeutic index, such as complicated pharmacokinetics and dynamics. Many drug interactions may occur when the administration of one drug alters the clinical effects of another. As a result, digoxin toxicity can be a common condition within clinical settings that might lead to the development of many morbidities and even mortality. Many studies were published to investigate the efficacy and safety of different management modalities to enhance the outcomes that follow digoxin administration. The aim of the study was to discuss the approaches to systematically treat and prevent the development of cardiac digoxin toxicity. The findings are based on evidence from previous studies in the literature. To be specific, Fab fragments are the most effective modalities that can be used to treat severe cases within ideal periods. However, evidence regarding their administration for asymptomatic or mild cases is still poor regarding the cost-efficacy and the development of serious adverse events. Physicians should primarily care for a better intervention as it is usually associated with a significantly more enhanced prognosis and clinical outcomes. Nevertheless, adequate monitoring of the patients and evaluation of their personal and medical history are important steps in the process, and further approaches are still needed. Also, detailed information about our intended outcomes is furtherly discussed within the manuscript.

show abstract

Section: Management Of Digitalis Toxicitymentioning

confidence: 99%

Systematic treatment and prevention of cardiac digoxin toxicity

Alshaer

Binobaid

Mofti

et al. 2021

Int J Community Med Public Health

View full text Add to dashboard Cite

show abstract

“…4 However, the COVID-19 disease can be severe in some cases where there might be severe organ damage leading to some complications related to the lungs, kidney, liver, and central nervous system. [5][6][7][8][9][10] Moreover, pulmonary manifestations remain the most common manifestations that can be observed among these patients and some studies have reported that the pulmonary findings can be used to diagnose or suspect the infection, and predict the prognosis of the disease. 7 CT of the chest has been previously reported as an efficacious approach for the early diagnosis and suspicion of COVID-19 infection, as diagnosis with other modalities is usually timeconsuming and cannot detect the disease within the early stages.…”

Section: Introductionmentioning

confidence: 99%

Early and late pulmonary manifestations of COVID-19 on computed tomography scan

Kaabi

Madkhali

Alqahtani

et al. 2021

Int J Community Med Public Health

View full text Add to dashboard Cite

Computed tomography (CT) of the chest has been previously reported as an efficacious approach for the early diagnosis and suspicion of COVID-19 infection, as diagnosis with other modalities is usually time-consuming and cannot detect the disease within the early stages. Many pulmonary manifestations have been previously observed under CT imaging of the chest. All of them have been linked with the different stages of the disease, indicating their abilities to diagnose and follow-up these patients.This present literature review aims to discuss the role of CT imaging of the chest in COVID-19 infections and it also aims to elaborate the common pulmonary manifestations that can be frequently observed to help with the diagnosis and prognosis of the disease. Moreover, ground-glass opacities (GGOs) have been reported among studies in the literature to be the most common findings as they remain the earliest among other diseases. The literature review also aims to invistagate whether GGOs can fade away or progress to consolidate in order to decide the prognosis of the disease and to identify the severity of cases. Consolidations have also been previously stated among studies in the literature as frequent pulmonary manifestations affecting patients with COVID-19 infections and are estimated to be present in 2-63% of patients with COVID-19 infections. Other pulmonary manifestations might also include bronchiectasis, lymphadenopathy, nodules, pleural effusion or thickening, and halo sign.

show abstract

Full recovery of a patient with COVID-19-induced acute kidney injury

Cited by 2 publications

References 0 publications

Systematic treatment and prevention of cardiac digoxin toxicity

Systematic treatment and prevention of cardiac digoxin toxicity

Early and late pulmonary manifestations of COVID-19 on computed tomography scan

Contact Info

Product

Resources

About